PharmaShots | Incisive News in 3 Shots

Subscribe Now

Advanced NSCLC

Regeneron and Sanofi's Libtayo (cemiplimab) Receive the EC's Approval as 1L Treatment for Advanced NSCLC

Regeneron and Sanofi's Libtayo (cemiplimab) Receive the EC's Approval as 1L Treatment for Advanced NSCLC

June 25, 2021

Regeneron and Sanofi's Libtayo (cemiplimab-rwlc) Receive the US FDA's Approval as 1L Treatment for Advanced NSCLC

Regeneron and Sanofi's Libtayo (cemiplimab-rwlc) Receive the US FDA's Approval as 1L Treatment for Advanced NSCLC

February 23, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us